Effects of hypochlorite-modified low density and high density lipoproteins on intracellular Ca2+ and plasma membrane Ca2+-ATPase activity of human platelets

Cell Calcium

Volumn 26, Issue 6, 1999, Pages 281-287

  Zabe, M ^a   Feltzer, R E ^a   Malle, E ^b   Sattler, W ^b   Dean, W L ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CHLORIDE ION; COPPER ION; HIGH DENSITY LIPOPROTEIN; HYDROGEN PEROXIDE; HYPOCHLORITE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; OXIDIZING AGENT;

ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE FUNCTION;

EID: 0033373346     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1054/ceca.1999.0081     Document Type: Article

References (45)

1. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 52:1983;223-261.
2. Fielding C. J., Fielding P. E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
3. Palinski W., Rosenfeld M. E., Yla-Herttuala S. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
4. Berliner J. A., Heinecke J. W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 20:1996;707-727.
5. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8:1994;1279-1284.
6. Thomas E. L., Grisham M. B., Jefferson M. M. Myeloperoxidase-dependent effects of amines on functions of isolated neutrophils. J Clin Invest. 72:1983;441-454.
7. Lampert M. B., Weiss S. J. The chlorinating potential of the human monocyte. Blood. 62:1983;645-651.
8. Winterbourn C. C. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta. 840:1985;204-210.
9. Hazell L. J., Stocker R. Oxidation of low density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J. 290:1993;165-172.
10. Panzenboeck U., Raitmayer S., Reicher H. Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem. 272:1997;29711-29720.
11. Hazell L. J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 97:1996;1535-1544.
12. Marcus A. J., Safier L. B. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 7:1993;516-522.
13. Koller E., Koller F., Binder B. R. Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane. J Biol Chem. 264:1989;12412-12418.
14. Malle E., Ibovnik A., Steinmetz A., Kostner G. M., Sattler W. Binding of lipoprotein(a), Lp(a), to intact, resting human blood platelets and isolated platelet membrane protein fractions. Arterioscler Thromb. 14:1994;70-83.
15. Malle E., Sattler W. Platelets and the lipoproteins: native, modified and platelet modified lipoproteins. Platelets. 5:1994;70-83.
16. Endemann G., Stanton L. W., Madden K. S., Bryant C. M., White R. T., Protter A. A. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11811-11816.
17. Ardlie N. G., Selley M. L., Simons L. A. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis. Atherosclerosis. 76:1989;117-124.
18. Takahashi Y., Chiba H., Matsuno. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins. Biochem Biophys Res Commun. 222:1996;453-459.
19. Zhao B., Dierichs R., Harrach-Ruprecht B., Winterhoff H. Oxidized LDL induces serotonin release from blood platelets. Am J Hematol. 48:1995;285-287.
20. 2+-ATPase. Cell Calcium. 19:1996;453-458.
21. Aviram M. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb Res. 53:1989;561-567.
22. Meraji S., Moore C. E., Skinner V. O., Bruckdorfer K. R. The importance of oxidation or glycosylation of low-density lipoproteins in relation to platelet activation. Platelets. 3:1992;155-162.
23. Rink T. S., Sage S. O. Ca2+-signaling in human platelets. Annu Rev Physiol. 52:1990;431-449.
24. Haynes D. H. Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization. Platelets. 4:1993;231-242.
25. Dunn R. C., Schachter M., Miles C. M. M. Low-density lipoprotein increases intracellular calcium in aequorin - loaded platelets. FEBS Lett. 238:1988;357-360.
26. Malle E., Hazell L. J., Stocker R., Sattler W., Esterbauer H., Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol. 15:1995;982-989.
27. Malle E., Ibovnik A., Leis H. J., Kostner G. M., Verhallen P. F. J., Sattler W. Lysine modification of LDL and lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation. Arterioscler Thromb Vasc Biol. 15:1995;377-384.
28. Steinbrecher U. P. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem. 262:1987;3603-3608.
29. Harmon J. T., Greco N. J., Jamieson G. A. Isolation of human platelet plasma membranes by glycerol lysis. Methods Enzymol. 215:1992;32-36.
30. Dean W. L., Quinton T. M. Distribution of plasma membrane Ca(2+)-ATPase and inositol 1,4,5-trisphosphate receptor in human platelet membranes. Cell Calcium. 17:1995;65-70.
31. Smith P. K., Krohn R. J., Hermanson G. T. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
32. 2+-pump from human and porcine platelets. Methods Enzymol. 157:1988;351-360.
33. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
34. -. Free Rad Biol Med. 16:1994;143-148.
35. Malle E., Woenckhaus C., Waeg G., Esterbauer H., Grone E., Grone H-J. Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol. 150:1997;603-615.
36. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 94:1994;437-444.
37. Opper C., Schuessler G., Sattler W., Malle E. Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function. Platelets. 9:1998;339-341.
38. Sattler W., Kostner G. M., Waeg G., Esterbauer H. Oxidation of lipoprotein Lp(a). A comparison with low density lipoproteins. Biochim Biophys Acta. 1081:1991;65-74.
39. Ryu B. H., Mao F. W., Lou P., Gutman R. L., Greenspan P. Cholesteryl ester accumulation in macrophages treated with oxidized low density lipoprotein. Biosci Biotech Biochem. 59:1995;1619-1622.
40. Shmulewitz A., Brook J. G., Aviram M. Native and modified low density lipoprotein interaction with human platelets in normal and homozygous familial hypercholesterolaemic subjects. Biochem J. 224:1984;13-20.
41. Desai K., Brockdorfer K. R., Hutton R. A., Owens J. S. Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation. J Lipid Res. 30:1989;831-840.
42. Zhao B., Dierichs R., Liu B., Holling-Rau M. Functional and morphological alterations of human blood platelets induced by oxidized low density lipoprotein. Thromb Res. 74:1994;293-301.
43. Zhao B., Dierichs R., Liu B., Zhu Z. M., Berkes P., Frye S. Influence of low density lipoproteins on cytosolic Ca2+ concentration and dense tubular system in human platelets. Thromb Res. 72:1992;33-37.
44. Carafoli E. Calcium pump of the plasma membrane. Physiol Rev. 71:1991;129-150.
45. Katrantzis M., Baker M. S., Handley C. J., Lowther D. A. The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate. Free Radic Res Med. 10:1991;101-109.